|Wolters Kluwer N V -- USA Stock|| |
USD 48 0.32 0.67%
Member of the Supervisory Board and Member of Audit Committee
Mr. Bruno F. J. Angelici was Member of the Supervisory Board of Wolters Kluwer N.V. since April 20, 2007. He holds a Juris Doctor degree from Reims Management School and a Masters of Business Administration from Kellogg School of Management. He is former Executive Vice President, Europe, Japan, Asia Pacific, Latin America, Middle East, and Africa of AstraZeneca Plc
Age: 68 Executive Since 2007
31 172 641 400 http://www.wolterskluwer.com
Angelici has served as Member of the Board of Smiths Group plc, Member of the Board of Novo Nordisk A/S and Member of the Global Advisory Board of Takeda Pharmaceuticals Ltd. . He is Member of the Company Audit Committee.
The company has return on total asset (ROA)
of 6.12 %
which means that it generated profit of $6.12 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 23.13 %
meaning that it generated $23.13 on every $100 dollars invested by stockholders.
The company has accumulated 3.94 B in total debt with debt to equity ratio (D/E) of 135.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Wolters Kluwer N V has Current Ratio of 0.65 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Wolters Kluwer N.V., together with its subsidiaries, offer information, software, and services in Europe, North America, the Asia Pacific, and internationally. Wolters Kluwer N V (WTKWY) is traded on OTC Market in USA. It is located in Alphen aan den Rijn, BA and employs 19,000 people.